Spok Holdings Inc (SPOK) - Net Assets
Based on the latest financial reports, Spok Holdings Inc (SPOK) has net assets worth $140.96 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($193.89 Million) and total liabilities ($52.93 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Spok Holdings Inc total assets for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $140.96 Million |
| % of Total Assets | 72.7% |
| Annual Growth Rate | N/A |
| 5-Year Change | -15.72% |
| 10-Year Change | -54.55% |
| Growth Volatility | 45.16 |
Spok Holdings Inc - Net Assets Trend (2000–2025)
This chart illustrates how Spok Holdings Inc's net assets have evolved over time, based on quarterly financial data. Check tangible net worth ratio of Spok Holdings Inc to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Spok Holdings Inc (2000–2025)
The table below shows the annual net assets of Spok Holdings Inc from 2000 to 2025. For live valuation and market cap data, see Spok Holdings Inc market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $146.38 Million | -5.41% |
| 2024-12-31 | $154.75 Million | -5.51% |
| 2023-12-31 | $163.77 Million | -4.83% |
| 2022-12-31 | $172.08 Million | -0.93% |
| 2021-12-31 | $173.69 Million | -13.42% |
| 2020-12-31 | $200.61 Million | -19.78% |
| 2019-12-31 | $250.09 Million | -8.91% |
| 2018-12-31 | $274.55 Million | -5.50% |
| 2017-12-31 | $290.53 Million | -9.80% |
| 2016-12-31 | $322.09 Million | -3.44% |
| 2015-12-31 | $333.55 Million | +19.53% |
| 2014-12-31 | $279.06 Million | +3.37% |
| 2013-12-31 | $269.95 Million | +7.37% |
| 2012-12-31 | $251.42 Million | -0.40% |
| 2011-12-31 | $252.44 Million | +36.91% |
| 2010-12-31 | $184.39 Million | +16.12% |
| 2009-12-31 | $158.80 Million | +12.83% |
| 2008-12-31 | $140.74 Million | -62.33% |
| 2007-12-31 | $373.57 Million | -21.51% |
| 2006-12-31 | $475.97 Million | -10.70% |
| 2005-12-31 | $532.99 Million | -8.63% |
| 2004-12-31 | $583.34 Million | +78.79% |
| 2003-12-31 | $326.26 Million | +185.64% |
| 2002-12-31 | $114.22 Million | +106.89% |
| 2001-12-31 | $-1.66 Billion | -1657.73% |
| 2000-12-31 | $-94.26 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Spok Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3992100000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $39.92 Million | 27.27% |
| Common Stock | $2.00K | 0.00% |
| Other Comprehensive Income | $-1.76 Million | -1.20% |
| Other Components | $108.21 Million | 73.93% |
| Total Equity | $146.38 Million | 100.00% |
Spok Holdings Inc Competitors by Market Cap
The table below lists competitors of Spok Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
RoadMain T Co Ltd
SHG:603860
|
$221.30 Million |
|
Synopex Inc
KQ:025320
|
$221.31 Million |
|
Taiwan Kong King Co Ltd
TWO:3093
|
$221.34 Million |
|
Laboratorio Reig Jofre S.A
MC:RJF
|
$221.39 Million |
|
Huafang Co Ltd
SHG:600448
|
$221.19 Million |
|
EVI Industries Inc
NYSE MKT:EVI
|
$221.18 Million |
|
Celon Pharma SA
WAR:CLN
|
$221.14 Million |
|
Neon Equity AG
XETRA:D77
|
$221.13 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Spok Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 154,746,000 to 146,379,000, a change of -8,367,000 (-5.4%).
- Net income of 15,881,000 contributed positively to equity growth.
- Dividend payments of 27,259,000 reduced retained earnings.
- Share repurchases of 2,843,000 reduced equity.
- Other comprehensive income increased equity by 28,000.
- Other factors increased equity by 5,826,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $15.88 Million | +10.85% |
| Dividends Paid | $27.26 Million | -18.62% |
| Share Repurchases | $2.84 Million | -1.94% |
| Other Comprehensive Income | $28.00K | +0.02% |
| Other Changes | $5.83 Million | +3.98% |
| Total Change | $- | -5.41% |
Book Value vs Market Value Analysis
This analysis compares Spok Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.52x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2000-12-31 | $-1.25 | $10.59 | x |
| 2001-12-31 | $-19.54 | $10.59 | x |
| 2002-12-31 | $1.30 | $10.59 | x |
| 2003-12-31 | $16.30 | $10.59 | x |
| 2004-12-31 | $27.82 | $10.59 | x |
| 2005-12-31 | $19.43 | $10.59 | x |
| 2006-12-31 | $17.26 | $10.59 | x |
| 2007-12-31 | $13.61 | $10.59 | x |
| 2008-12-31 | $5.22 | $10.59 | x |
| 2009-12-31 | $6.83 | $10.59 | x |
| 2010-12-31 | $8.17 | $10.59 | x |
| 2011-12-31 | $11.21 | $10.59 | x |
| 2012-12-31 | $11.23 | $10.59 | x |
| 2013-12-31 | $12.26 | $10.59 | x |
| 2014-12-31 | $12.63 | $10.59 | x |
| 2015-12-31 | $15.74 | $10.59 | x |
| 2016-12-31 | $15.65 | $10.59 | x |
| 2017-12-31 | $14.38 | $10.59 | x |
| 2018-12-31 | $13.96 | $10.59 | x |
| 2019-12-31 | $13.10 | $10.59 | x |
| 2020-12-31 | $10.54 | $10.59 | x |
| 2021-12-31 | $8.95 | $10.59 | x |
| 2022-12-31 | $8.61 | $10.59 | x |
| 2023-12-31 | $8.05 | $10.59 | x |
| 2024-12-31 | $7.52 | $10.59 | x |
| 2025-12-31 | $6.95 | $10.59 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Spok Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.85%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.37%
- • Asset Turnover: 0.68x
- • Equity Multiplier: 1.41x
- Recent ROE (10.85%) is below the historical average (58.90%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 0.00% | -36.40% | 0.37x | 0.00x | $-300.35 Million |
| 2001 | 0.00% | -134.86% | 1.79x | 0.00x | $-1.40 Billion |
| 2002 | 1449.42% | 202.21% | 1.85x | 3.88x | $1.64 Billion |
| 2003 | 3.99% | 2.18% | 1.21x | 1.52x | $-19.62 Million |
| 2004 | 2.31% | 2.75% | 0.62x | 1.36x | $-44.85 Million |
| 2005 | 2.42% | 2.09% | 0.98x | 1.19x | $-40.39 Million |
| 2006 | 8.44% | 8.07% | 0.85x | 1.24x | $-7.42 Million |
| 2007 | -1.39% | -1.22% | 0.88x | 1.30x | $-42.55 Million |
| 2008 | -111.61% | -43.70% | 1.49x | 1.71x | $-171.15 Million |
| 2009 | 42.54% | 23.32% | 1.36x | 1.34x | $51.68 Million |
| 2010 | 42.25% | 33.40% | 1.01x | 1.25x | $59.46 Million |
| 2011 | 35.11% | 36.49% | 0.69x | 1.39x | $63.40 Million |
| 2012 | 12.74% | 19.03% | 0.52x | 1.28x | $6.90 Million |
| 2013 | 10.20% | 13.13% | 0.64x | 1.21x | $535.00K |
| 2014 | 7.43% | 10.36% | 0.59x | 1.21x | $-7.16 Million |
| 2015 | 25.25% | 44.42% | 0.49x | 1.17x | $50.88 Million |
| 2016 | 4.34% | 7.79% | 0.46x | 1.20x | $-18.23 Million |
| 2017 | -5.27% | -8.94% | 0.49x | 1.21x | $-44.36 Million |
| 2018 | -0.54% | -0.87% | 0.52x | 1.19x | $-28.93 Million |
| 2019 | -4.30% | -6.72% | 0.50x | 1.29x | $-35.77 Million |
| 2020 | -22.04% | -29.85% | 0.53x | 1.38x | $-64.29 Million |
| 2021 | -12.77% | -15.60% | 0.57x | 1.43x | $-39.55 Million |
| 2022 | 12.70% | 16.25% | 0.55x | 1.42x | $4.65 Million |
| 2023 | 9.57% | 11.27% | 0.61x | 1.39x | $-711.10K |
| 2024 | 9.67% | 10.87% | 0.63x | 1.40x | $-509.60K |
| 2025 | 10.85% | 11.37% | 0.68x | 1.41x | $1.24 Million |
Industry Comparison
This section compares Spok Holdings Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $371,778,135
- Average return on equity (ROE) among peers: -245.44%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Spok Holdings Inc (SPOK) | $140.96 Million | 0.00% | 0.38x | $221.19 Million |
| Aclarion Inc (ACON) | $2.23 Million | -317.55% | 0.31x | $1.41 Million |
| American Well Corp (AMWL) | $1.26 Billion | -13.99% | 0.15x | $133.17 Million |
| Heartbeam Inc (BEAT) | $70.00 Million | -17.43% | 0.29x | $28.40 Million |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $-1.01 Million | 0.00% | 0.00x | $6.51 Million |
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $800.46 Million | 6.22% | 5.89x | $10.63 Billion |
| Carlsmed, Inc. Common Stock (CARL) | $-46.13 Million | 0.00% | 0.00x | $293.60 Million |
| CareCloud, Inc. (CCLD) | $118.50K | -150.21% | 47.72x | $94.33 Million |
| Certara Inc (CERT) | $1.04 Billion | -1.27% | 0.45x | $1.12 Billion |
| CareMax Inc (CMAX) | $505.37 Million | -1.32% | 0.29x | $381.50 |
| Claritev Corporation (CTEV) | $84.02 Million | -1958.81% | 60.30x | $368.40 Million |
About Spok Holdings Inc
Spok Holdings, Inc., through its subsidiary, Spok, Inc., engages in the healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. Its products and services enhance workflows for clinicians and support administrative compliance. The company delivers clinical information to care teams when and where it matters to enhance patient outcomes; and pro… Read more